ASTRAZENECA PHARMA Plunges by 8%; BSE HEALTHCARE Index Down 3.5%
March 19, 2020 09:20 AM

ASTRAZENECA PHARMA share price has plunged 8% and is presently trading at Rs 2,415.

Meanwhile, the BSE HEALTHCARE Index is at 11,441 (down 3.5%).

Among the top losers in the BSE HEALTHCARE Index today are ASTRAZENECA PHARMA (down 8.4%) and PROCTER & GAMBLE HEALTH (down 6.8%).

NARAYANA HRUDAYALAYA LTD (up 0.6%) and WOCKHARDT (up 0.5%) are among the top gainers today.

Over the last one year, ASTRAZENECA PHARMA has moved up from Rs 1,950 to Rs 2,415, registering a gain of Rs 465 (up 23.8%)..

The BSE HEALTHCARE has moved down from 14,216 to 11,441, loss of 2,775 points (down 19.5%) during the last 12 months.

The top gainers among the BSE HEALTHCARE Index stocks during this same period were ABBOTT INDIA (up 93.3%), J.B.CHEMICALS (up 50.7%) and IPCA LABS (up 44.0%).

What About the Benchmark Indices?

The BSE Sensex is at 27,773 (down 5.6%). The top gainers among the BSE Sensex stocks today are POWER GRID (up 1.4%) and ITC (up 0.2%). The most traded stocks in the BSE Sensex are ITC and POWER GRID.

In the meantime, NSE Nifty is at 8,063 (down 4.8%). YES BANK (up 2.0%) and POWER GRID (up 0.9%) are among the top gainers in NSE Nifty.

Over the last 12 months, the BSE Sensex has moved down from 38,095 to 27,773, registering a loss of 10,322 points (down 28.43%).

ASTRAZENECA PHARMA Financial Update...

ASTRAZENECA PHARMA net profit down at Rs 144 million for the quarter ended September 2019, compared to a loss of Rs 291 million a year ago. Net Sales declined 3.1% to Rs 2.1 billion during the period as against Rs 2.2 billion in July-September 2018.

For the year ended March 2018, ASTRAZENECA PHARMA reported 29.2% increase in net profit to Rs 259.0 million compared to net profit of Rs 200.0 million during FY17.

Revenue of the company grew 4.3% to Rs 6 billion during FY18.

The current Price to earnings ratio of ASTRAZENECA PHARMA, based on rolling 12 month earnings, stands at 68.2x.